Diabetes and Ramadan: Practical guidelines.
Mohamed Hassanein,Monira Al-Arouj,Osama Hamdy,Wan Mohamad Wan Bebakar,Abdul Jabbar,Abdulrazzaq Al-Madani,Wasim Hanif,Nader Lessan,Abdul Basit,Khaled Tayeb,Mak Omar,Khalifa Abdallah,Abdulaziz Al Twaim,Mehmet Akif Buyukbese,Adel Abdel Aziz El-Sayed,Abdullah Bennakhi +15 more
Reads0
Chats0
TLDR
The IDF-DAR Practical Guidelines should enhance knowledge surrounding the issue of diabetes and Ramadan fasting, thereby empowering healthcare professionals to give the most up-to-date advice and the best possible support to their patients during Ramadan.About:
This article is published in Diabetes Research and Clinical Practice.The article was published on 2017-04-01 and is currently open access. It has received 247 citations till now.read more
Citations
More filters
Journal ArticleDOI
RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017
TL;DR: Members: Dr. S. R. Rao, Dr Rajeev Chawla, Dr Rakesh Sahay, Dr. Samar Banerjee, Sanjay Agarwal, Dr Sanjay Kalra,Dr.
Journal ArticleDOI
Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus
Mahmoud Ibrahim,Melanie J. Davies,Ehtasham Ahmad,Firas A Annabi,Robert H. Eckel,Ebtesam M Ba-Essa,Nuha Ali El Sayed,Amy Hess Fischl,Pamela Houeiss,Hinde Iraqi,Ines Khochtali,Kamlesh Khunti,Shabeen Naz Masood,Safia Mimouni-Zerguini,Samad Shera,Jaakko Tuomilehto,Guillermo E. Umpierrez +16 more
TL;DR: The use of the emerging technology and continuous glucose monitoring during Ramadan could help to recognize hypoglycemic and hyperglycemic complications related to omission and/or medication adjustment during fasting; however, the cost represents a significant barrier.
Journal ArticleDOI
COVID-19 in people living with diabetes: An international consensus.
A.E. Caballero,A. Ceriello,A. Misra,Pablo Aschner,Marie E. McDonnell,M. Hassanein,Linong Ji,Jean Claude Mbanya,Vivian Fonseca +8 more
TL;DR: The worldwide experience of the COVID-19 pandemic offers the possibility to not only prepare better for future disasters but also transform diabetes care beyond the CO VID-19 era.
Journal ArticleDOI
EADSG Guidelines: Insulin Therapy in Diabetes
Bahendeka Silver,Kaushik Ramaiya,Swai Babu Andrew,Otieno Fredrick,Sarita Bajaj,Sanjay Kalra,Bavuma M. Charlotte,Karigire Claudine,Anthony Makhoba +8 more
TL;DR: Indications for exogenous insulin therapy in patients with type 2 diabetes mellitus (T2DM) include acute illness or surgery, pregnancy, glucose toxicity, contraindications to or failure to achieve goals with oral antidiabetic medications, and a need for flexible therapy.
Journal ArticleDOI
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020.
TL;DR: The present paper presents a meta-analysis of 148 cases of type 2 diabetes patients treated at the UCMS-GTB Hospital in Ahmedabad over a 12-month period from May 2013 to March 2014 that showed clear trends in disease progression and in particular in cases of high blood pressure and insulin resistance.
References
More filters
Journal ArticleDOI
Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study.
Mohamed Hassanein,Wasim Hanif,Waqar Malik,Ali Kamal,Parnia Geransar,Nicola Lister,Chris Andrews,Anthony H. Barnett +7 more
TL;DR: Vildagliptin caused no hypoglycaemia, was well adhered to and improved HbA1c, making it a suitable treatment option for managing fasting, when extrapolated to the global Muslim population with a similar clinical background.
Journal ArticleDOI
Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: Insights from continuous glucose monitoring (CGM)
TL;DR: The main change in glycaemic control with Ramadan fasting in patients with diabetes is in the pattern of excursions, and Ramadan fasting caused neither overall deterioration nor improvement in the majority of patients with good baseline glucose control.
Journal ArticleDOI
The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study
Monira Al-Arouj,Ahmed A.K. Hassoun,Rita C Medlej,M. F. Pathan,Inass Shaltout,M. S. Chawla,Sashka Hristoskova,S. DiTommaso,M. Y. Kadwa +8 more
TL;DR: To assess, in a real‐world setting, the effect of vildagliptin compared with sulphonylurea treatment on hypoglycaemia in Muslim patients with type 2 diabetes mellitus (T2DM) fasting during Ramadan, a comparison study is conducted.
Journal ArticleDOI
The effect of Ramadan fasting on maternal serum lipids, cortisol levels and fetal development.
TL;DR: The results of this study showed that maternal serum cortisol level was elevated while LDL/HDL ratio were decreased in healthy women with uncomplicated pregnancies of 20 weeks or more, who were fasting during Ramadan.
Journal ArticleDOI
Fasting and insulin glargine in individuals with type 1 diabetes.
TL;DR: The hypothesis that glargine insulin would maintain euglycemia in type 1 diabetic subjects during an 18-h fast, such as would occur when a person with type 1 diabetes sleeps late or misses meals, is tested.